Ben McDonald, the country president of AstraZeneca Australia and New Zealand, stated that the findings demonstrate the opportunity Australia has to reduce the health and economic burden of chronic kidney disease.
Early intervention on chronic kidney disease would deliver economic boost
June 8, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
LTR Pharma achieves key FDA milestone through extractables study
June 30, 2025 - - Australian Biotech -
Arovella Therapeutics announces the retirement of non-executive chair
June 30, 2025 - - Australian Biotech -
The focus on system and patient productivity is a new 'open door' opportunity
June 29, 2025 - - Latest News -
Incoming brief advises minister to dampen expectations on HTA Review
June 29, 2025 - - Latest News -
Incoming brief recommends doing more and reviewing less
June 28, 2025 - - Latest News -
The Dispatched 'Week in Review' Podcast - 27 June
June 27, 2025 - - Podcast -
Percheron licenses Phase 2 ready immuno-oncology candidate from Hummingbird
June 27, 2025 - - Australian Biotech